BRAF and neoplasm: It is recommended for example that pathologists ‘reflex’ arrange MMR tumour testing and MLH1 methylation and/or BRAF testing in all eligible patients, but that patient-facing clinicians receive and action the test reports to ensure eligible patients are offered constitutional testing in a systematic fashion.